Synthesis and identification of GZD856 as an orally bioavailable Bcr-AblT315I inhibitor overcoming acquired imatinib resistance
Author:
Affiliation:
1. School of Pharmacy, Jinan University, Guangzhou, China;
2. State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Funder
National High Technology Research and Development
Guangdong Natural Science Funds for Distinguished Young Scholar
Pearl River S&T Nova Program of Guangzhou
Guangdong Special Branch Program Technology Young Talents
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://tandfonline.com/doi/pdf/10.1080/14756366.2016.1250757
Reference29 articles.
1. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
2. Molecular biology of bcr-abl1–positive chronic myeloid leukemia
3. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
4. The development of imatinib as a therapeutic agent for chronic myeloid leukemia
5. Imatinib and beyond—exploring the full potential of targeted therapy for CML
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia;Biochemical Pharmacology;2023-12
2. The Progress of Small Molecule Targeting BCR-ABL in the Treatment of Chronic Myeloid Leukemia;Mini-Reviews in Medicinal Chemistry;2023-10-06
3. The progress of small-molecules and degraders against BCR-ABL for the treatment of CML;European Journal of Medicinal Chemistry;2022-08
4. Stepwise synthesis of 2,6-difunctionalized ethyl pyrazolo[1,5-a]pyrimidine-3-carboxylate via site-selective cross-coupling reactions: experimental and computational studies;Organic & Biomolecular Chemistry;2022
5. Recent advances in Bcr‐Abl tyrosine kinase inhibitors for overriding T315I mutation;Chemical Biology & Drug Design;2020-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3